Transdermally administered proline-arginine-rich host defense peptides show systemic efficacy in a lethal mouse bacteremia model

Abstract

Host defense peptides are preferably administered as topical therapeutic agents. We have investigated whether peptide A3-APO can enter the circulation when applied to the ear skin. Efficacy of peptide monotherapy as transdermal administration option was assessed in a systemic mouse Acinetobacter baumannii model. A3-APO reduced mortality and demonstrated a statistically significant reduction of blood bacterial counts, regardless whether it was administered prior or after bacterial challenge. The peptidic metabolite of A3-APO was efficacious when applied to the ear or tail.

Keywords: Bacterial counts; Multidrug resistance; Peptide antibiotic; Skin penetration; Survival.